These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Diagnosis and follow-up of acute promyelocytic leukemia by detection of PML-RAR alpha gene rearrangement. Gau JP, Young JH, Lin TH, Yang YS. Zhonghua Yi Xue Za Zhi (Taipei); 2000 Mar; 63(3):175-81. PubMed ID: 10746412 [Abstract] [Full Text] [Related]
3. The PML-RAR alpha transcript in long-term follow-up of acute promyelocytic leukemia patients. Gameiro P, Vieira S, Carrara P, Silva AL, Diamond J, Botelho de Sousa A, Mehta AB, Prentice HG, Guimarães JE, Hoffbrand AV, Foroni L, Parreira A. Haematologica; 2001 Jun; 86(6):577-85. PubMed ID: 11418366 [Abstract] [Full Text] [Related]
4. Absence of detectable PML-RAR alpha fusion transcripts in long-term remission patients after BMT for acute promyelocytic leukemia. Román J, Martín C, Torres A, Jiménez MA, Andrés P, Flores R, de la Torre MJ, Sánchez J, Serrano J, Falcón M. Bone Marrow Transplant; 1997 Apr; 19(7):679-83. PubMed ID: 9156244 [Abstract] [Full Text] [Related]
5. Occurrence of distinct PML-RAR-alpha fusion gene isoforms in patients with acute promyelocytic leukemia detected by reverse transcriptase/polymerase chain reaction. Chen SJ, Chen Z, Chen A, Tong JH, Dong S, Wang ZY, Waxman S, Zelent A. Oncogene; 1992 Jun; 7(6):1223-32. PubMed ID: 1375719 [Abstract] [Full Text] [Related]
8. [Quantification of PML/RAR alpha fusion gene transcripts in patients with acute promyelocytic leukemia by using real-time quantitative PCR]. Lin J, Han LX, Qian J, Wang YL, Qian Z, Yang XF, Sheng XJ. Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Jun; 25(3):319-21. PubMed ID: 18543226 [Abstract] [Full Text] [Related]
9. Variability in the levels of PML-RAR alpha fusion transcripts detected by the laboratories participating in an external quality control program using several reverse transcription polymerase chain reaction protocols. Bolufer P, Lo Coco F, Grimwade D, Barragán E, Diverio D, Cassinat B, Chomienne C, Gonzalez M, Colomer D, Gomez MT, Marugan I, Román J, Delgado MD, García-Marco JA, Bornstein R, Vizmanos JL, Martinez B, Jansen J, Villegas A, de Blas JM, Cabello P, Sanz MA. Haematologica; 2001 Jun; 86(6):570-6. PubMed ID: 11418365 [Abstract] [Full Text] [Related]
10. [Pilot study of PML/RAR alpha fusion by fluorescence in situ hybridization (FISH)method in acute promyelocyte leukemia]. Legües ME, Franco G, Bertin P. Rev Med Chil; 2002 Jul; 130(7):737-44. PubMed ID: 12235897 [Abstract] [Full Text] [Related]
11. Internal tandem duplication and Asp835 mutations of the FMS-like tyrosine kinase 3 (FLT3) gene in acute promyelocytic leukemia. Shih LY, Kuo MC, Liang DC, Huang CF, Lin TL, Wu JH, Wang PN, Dunn P, Lai CL. Cancer; 2003 Sep 15; 98(6):1206-16. PubMed ID: 12973844 [Abstract] [Full Text] [Related]
12. Analysis of peripheral blood progenitor cells demonstrates limitations of minimal residual disease diagnosis in a case of acute promyelocytic leukemia. Karlic HI, Mühlberger H, Pavlova BG, Pfeilstöcker M, Salamon J, Pittermann E, Heinz R, Koller E. Bone Marrow Transplant; 1995 Jun 15; 15(6):999-1000. PubMed ID: 7581106 [Abstract] [Full Text] [Related]
14. [Molecular study on the distinct isoforms of PML-RAR alpha fusion gene transcripts in acute promyelocytic leukemia]. Geng JP. Zhonghua Yi Xue Za Zhi; 1993 Apr 15; 73(4):197-200, 252. PubMed ID: 8395310 [Abstract] [Full Text] [Related]
15. Autologous bone marrow transplantation for acute promyelocytic leukemia in second remission: prognostic relevance of pretransplant minimal residual disease assessment by reverse-transcription polymerase chain reaction of the PML/RAR alpha fusion gene. Meloni G, Diverio D, Vignetti M, Avvisati G, Capria S, Petti MC, Mandelli F, Lo Coco F. Blood; 1997 Aug 01; 90(3):1321-5. PubMed ID: 9242568 [Abstract] [Full Text] [Related]
16. [Effect of antisense oligodeoxynucleotide (ASODN) to PML-RAR alpha fusion gene on acute promyelocytic leukemia cell line NB4]. Yu W, Sun B, Chen Z. Zhonghua Xue Ye Xue Za Zhi; 1998 May 01; 19(5):227-30. PubMed ID: 11243116 [Abstract] [Full Text] [Related]
17. Missense mutations in the PML/RARalpha ligand binding domain in ATRA-resistant As(2)O(3) sensitive relapsed acute promyelocytic leukemia. Marasca R, Zucchini P, Galimberti S, Leonardi G, Vaccari P, Donelli A, Luppi M, Petrini M, Torelli G. Haematologica; 1999 Nov 01; 84(11):963-8. PubMed ID: 10553155 [Abstract] [Full Text] [Related]
18. Targeting the PML/RAR alpha translocation product triggers apoptosis in promyelocytic leukemia cells. Nason-Burchenal K, Takle G, Pace U, Flynn S, Allopenna J, Martin P, George ST, Goldberg AR, Dmitrovsky E. Oncogene; 1998 Oct 08; 17(14):1759-68. PubMed ID: 9778041 [Abstract] [Full Text] [Related]
19. Detecting PML-RARalpha transcript in acute promyelocytic leukemia using real-time quantitative RT-PCR. Zhu HH, Liu YR, Qin YZ, Jiang B, Shan FX, Wu SL, Yang PD, Zhao J, Lu DP. Chin Med J (Engl); 2007 Oct 20; 120(20):1803-8. PubMed ID: 18028775 [Abstract] [Full Text] [Related]
20. Establishing the presence of the t(15;17) in suspected acute promyelocytic leukaemia: cytogenetic, molecular and PML immunofluorescence assessment of patients entered into the M.R.C. ATRA trial. M.R.C. Adult Leukaemia Working Party. Grimwade D, Howe K, Langabeer S, Davies L, Oliver F, Walker H, Swirsky D, Wheatley K, Goldstone A, Burnett A, Solomon E. Br J Haematol; 1996 Sep 20; 94(3):557-73. PubMed ID: 8790159 [Abstract] [Full Text] [Related] Page: [Next] [New Search]